Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-17 4:13 pm Purchase |
2024-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,978,168 12.800% |
291,026 (+7.89%) |
Filing History |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,672 0.000% |
-2,075,420 (-99.87%) |
Filing History |
| 2024-11-14 3:03 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 0 0.000% |
-1,700,000 (Position Closed) |
Filing History |
| 2024-04-15 6:10 pm Sale |
2024-04-03 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 1,700,000 5.810% |
-2,504,364 (-59.57%) |
Filing History |
| 2024-04-10 12:58 pm Sale |
2024-03-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 910,266 3.100% |
-2,467,834 (-73.05%) |
Filing History |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,377,120 4.700% |
-720,286 (-34.34%) |
Filing History |
| 2024-03-27 1:12 pm Purchase |
2024-03-14 | 13G | Immuneering Corporation IMRX |
Merrin Investors LLC | 2,770,386 9.460% |
365,000 (+15.17%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,078,092 7.100% |
-63,405 (-2.96%) |
Filing History |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,378,100 11.500% |
-241,460 (-6.67%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
2,097,406 7.200% |
760,970 (+56.94%) |
Filing History |
| 2024-01-16 4:37 pm Purchase |
2023-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,687,142 12.600% |
191,356 (+5.47%) |
Filing History |
| 2023-05-05 11:52 am Sale |
2023-04-30 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,336,436 4.600% |
-11,948 (-0.89%) |
Filing History |
| 2023-04-24 5:26 pm Purchase |
2023-04-20 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 4,204,364 14.420% |
1,918,183 (+83.90%) |
Filing History |
| 2023-02-14 3:13 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 2,286,181 8.660% |
33,553 (+1.49%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,619,560 13.700% |
431,055 (+13.52%) |
Filing History |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,141,497 8.100% |
83,349 (+4.05%) |
Filing History |
| 2023-02-08 4:15 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,495,786 13.100% |
138,507 (+4.13%) |
Filing History |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Immuneering Corporation IMRX |
BLACKROCK INC BLK |
1,348,384 5.100% |
-367,786 (-21.43%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,188,505 12.200% |
151,523 (+4.99%) |
Filing History |
| 2022-02-14 06:22 am Sale |
2021-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,058,148 7.800% |
-4,528 (-0.22%) |
Filing History |